Um Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
HöfuðstöðvarCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Stofnað2013
StaðaVirkt
Einkaleyfi60 einkaleyfi
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Skráðu þig inn til að sjá öll 60 einkaleyfin
Skoðaðu allt einkaleyfasafnið, með birtingarnúmerum, dagsetningum og fjölskyldum.
Skrá inn Stofna reikning með netfanginu þínuÞað er ókeypis
Með því að halda áfram samþykkir þú notendasamning, persónuverndarstefnu og vefkökustefnu Heelky.
Umsagnir
Engar umsagnir enn. Hefurðu unnið með Onyx Pharmaceuticals, Inc.? Vertu fyrst til að deila reynslu þinni.
Lagalegar upplýsingar
| Lagaheiti | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Skoða á GLEIF ↗ |
| Skráð heimilisfang | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Staða | Virkt |
Heimildir: GLEIF · uppfært 16. október 2026
Tengiliðir og tenglar
Staðsetning
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Er þetta fyrirtækið þitt?
Gerðu ókeypis tilkall til þessarar síðu til að bæta við merki, vörum, myndum og störfum og til að svara umsögnum.
Gera tilkall til þessarar síðuGakktu til liðs við Heelky til að tengjast, ráða og vaxa
Stofnaðu ókeypis reikning til að senda fólki skilaboð, sækja um störf og birta verkefni.
Gakktu til liðs núna — það er ókeypis